By participating in the BOTOX® Savings Program, you acknowledge and agree to the full Terms & Conditions set out at BOTOXSavingsProgram.com/TermsandConditions. Patients enrolled in Medicare, Medicaid, TRICARE, or any other government-reimbursed healthcare program are not eligible. Other restrictions and maximum limits apply.
Get money back on out-of-pocket costs not covered by your commercial insurance–up to $1000 per treatment.
BOTOX® is a proven option for severe underarm sweating when antiperspirants fail. Treatment can last up to 201 days—that’s 6.7 months. Individual results may vary.
Your dermatologist will make 10 to 15 small injections into the affected underarm area through a very fine needle.1 You should notice a significant reduction in underarm sweating within 4 weeks of your first treatment.1 If you do not see a significant reduction in sweating, you should contact your dermatologist and request a follow-up consultation.
You can experience drier underarms for up to 201 days or 6.7 months.1 Individual results may vary.
Keep in mind that BOTOX® is not a cure for severe underarm sweating. Your symptoms will return gradually, and you’ll know when the time is right for another treatment.1 Your healthcare provider can recommend a treatment strategy.
Indication
BOTOX® is injected into the skin to treat the symptoms of severe underarm sweating (severe primary axillary hyperhidrosis) when medicines used on the skin (topical) do not work well enough in people 18 years and older.
It is not known whether BOTOX® is safe or effective for severe sweating anywhere other than your armpits.
IMPORTANT SAFETY INFORMATION
BOTOX® may cause serious side effects that can be life threatening. Get medical help right away if you have any of these problems any time (hours to weeks) after injection of BOTOX®:
There has not been a confirmed serious case of spread of toxin effect away from the injection site when BOTOX® has been used at the recommended dose to treat severe underarm sweating.
BOTOX® may cause loss of strength or general muscle weakness, vision problems, or dizziness within hours to weeks of taking BOTOX®. If this happens, do not drive a car, operate machinery, or do other dangerous activities.
Do not take BOTOX® if you: are allergic to any of the ingredients in BOTOX® (see Medication Guide for ingredients); had an allergic reaction to any other botulinum toxin product such as Myobloc® (rimabotulinumtoxinB), Dysport® (abobotulinumtoxinA), or Xeomin® (incobotulinumtoxinA); have a skin infection at the planned injection site.
The dose of BOTOX® is not the same as, or comparable to, another botulinum toxin product.
Serious and/or immediate allergic reactions have been reported including itching, red itchy welts, wheezing, asthma symptoms, or dizziness or feeling faint. Get medical help right away if you experience symptoms; further injection of BOTOX® should be discontinued.
Tell your doctor about all your muscle or nerve conditions such as ALS or Lou Gehrig’s disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may be at increased risk of serious side effects including difficulty swallowing and difficulty breathing from typical doses of BOTOX®.
Tell your doctor about all your medical conditions, including if you: have or have had bleeding problems; have plans to have surgery; had surgery on your face; weakness of forehead muscles; trouble raising your eyebrows; drooping eyelids; any other abnormal facial change; are pregnant or plan to become pregnant (it is not known if BOTOX® can harm your unborn baby); are breastfeeding or plan to (it is not known if BOTOX® passes into breast milk).
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using BOTOX® with certain other medicines may cause serious side effects. Do not start any new medicines until you have told your doctor that you have received BOTOX® in the past.
Tell your doctor if you received any other botulinum toxin product in the last 4 months; have received injections of botulinum toxin such as Myobloc®, Dysport®, or Xeomin® in the past (tell your doctor exactly which product you received); have recently received an antibiotic by injection; take muscle relaxants; take an allergy or cold medicine; take a sleep medicine; take aspirin-like products or blood thinners.
Other side effects of BOTOX® include: dry mouth, discomfort or pain at the injection site, tiredness, headache, neck pain, eye problems: double vision, blurred vision, decreased eyesight, drooping eyelids, swelling of your eyelids, dry eyes; and drooping eyebrows.
For more information refer to the Medication Guide or talk with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see BOTOX® full Product Information including Boxed Warning and Medication Guide.
References: 1. BOTOX® Prescribing Information, February 2021. 2. U.S. National Library of Medicine. National Institutes of Health (NIH). MedlinePlus website. http://www.nlm.nih.gov/medlineplus/ency/article/007259.htm. Updated June 4, 2018. Accessed August 17, 2021. 3. U.S. National Library of Medicine. National Institutes of Health (NIH). MedlinePlus website. http://www.nlm.nih.gov/medlineplus/ency/article/003218.htm. Updated June 4, 2018. Accessed June 25, 2018. 4. Solish N, Bertucci V, Dansereau A, et al. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg. 2007;33(8):908-923. 5. American Academy of Dermatology (AAD). Hyperhidrosis: Diagnosis and treatment. AAD website. https://aad.org/public/diseases/dry-sweaty-skin/hyperhidrosis. Accessed February 27, 2020. 6. International Hyperhidrosis Society. OnabotulinumtoxinA Injections (BOTOX®). International Hyperhidrosis Society website. http://www.sweathelp.org/en/hyperhidrosis-treatments/botox.html. Updated 2014. Accessed February 27, 2020.
BOTOX® and its design are registered trademarks of Allergan, Inc., an AbbVie company.
© 2023 AbbVie. All rights reserved.
BMD62525-v6 09/21 011695
This site is intended for US consumers only. No information on this site is provided with the intention to give medical advice or instructions on the accurate use of Allergan® products. Allergan® cannot answer unsolicited emails requesting personal medical advice; visitors should always consult a healthcare professional. Please visit the Allergan® site of your country of residence for information concerning Allergan® products and services available there.
Indication
BOTOX® is injected into the skin to treat the symptoms of severe underarm sweating (severe primary axillary hyperhidrosis) when medicines used on the skin (topical) do not work well enough in people 18 years and older.
It is not known whether BOTOX® is safe or effective for severe sweating anywhere other than your armpits.
IMPORTANT SAFETY INFORMATION
BOTOX® may cause serious side effects that can be life threatening. Get medical help right away if you have any of these problems any time (hours to weeks) after injection of BOTOX®:
There has not been a confirmed serious case of spread of toxin effect away from the injection site when BOTOX® has been used at the recommended dose to treat severe underarm sweating.
BOTOX® may cause loss of strength or general muscle weakness, vision problems, or dizziness within hours to weeks of taking BOTOX®. If this happens, do not drive a car, operate machinery, or do other dangerous activities.
Do not take BOTOX® if you: are allergic to any of the ingredients in BOTOX® (see Medication Guide for ingredients); had an allergic reaction to any other botulinum toxin product such as Myobloc® (rimabotulinumtoxinB), Dysport® (abobotulinumtoxinA), or Xeomin® (incobotulinumtoxinA); have a skin infection at the planned injection site.
The dose of BOTOX® is not the same as, or comparable to, another botulinum toxin product.
Serious and/or immediate allergic reactions have been reported including itching, red itchy welts, wheezing, asthma symptoms, or dizziness or feeling faint. Get medical help right away if you experience symptoms; further injection of BOTOX® should be discontinued.
Tell your doctor about all your muscle or nerve conditions such as ALS or Lou Gehrig’s disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may be at increased risk of serious side effects including difficulty swallowing and difficulty breathing from typical doses of BOTOX®.
Tell your doctor about all your medical conditions, including if you: have or have had bleeding problems; have plans to have surgery; had surgery on your face; weakness of forehead muscles; trouble raising your eyebrows; drooping eyelids; any other abnormal facial change; are pregnant or plan to become pregnant (it is not known if BOTOX® can harm your unborn baby); are breastfeeding or plan to (it is not known if BOTOX® passes into breast milk).
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using BOTOX® with certain other medicines may cause serious side effects. Do not start any new medicines until you have told your doctor that you have received BOTOX® in the past.
Tell your doctor if you received any other botulinum toxin product in the last 4 months; have received injections of botulinum toxin such as Myobloc®, Dysport®, or Xeomin® in the past (tell your doctor exactly which product you received); have recently received an antibiotic by injection; take muscle relaxants; take an allergy or cold medicine; take a sleep medicine; take aspirin-like products or blood thinners.
Other side effects of BOTOX® include: dry mouth, discomfort or pain at the injection site, tiredness, headache, neck pain, eye problems: double vision, blurred vision, decreased eyesight, drooping eyelids, swelling of your eyelids, dry eyes; and drooping eyebrows.
For more information refer to the Medication Guide or talk with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see BOTOX® full Product Information including Boxed Warning and Medication Guide.
References: 1. BOTOX® Prescribing Information, February 2021. 2. U.S. National Library of Medicine. National Institutes of Health (NIH). MedlinePlus website. http://www.nlm.nih.gov/medlineplus/ency/article/007259.htm. Updated June 4, 2018. Accessed August 17, 2021. 3. U.S. National Library of Medicine. National Institutes of Health (NIH). MedlinePlus website. http://www.nlm.nih.gov/medlineplus/ency/article/003218.htm. Updated June 4, 2018. Accessed June 25, 2018. 4. Solish N, Bertucci V, Dansereau A, et al. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg. 2007;33(8):908-923. 5. American Academy of Dermatology (AAD). Hyperhidrosis: Diagnosis and treatment. AAD website. https://aad.org/public/diseases/dry-sweaty-skin/hyperhidrosis. Accessed February 27, 2020. 6. International Hyperhidrosis Society. OnabotulinumtoxinA Injections (BOTOX®). International Hyperhidrosis Society website. http://www.sweathelp.org/en/hyperhidrosis-treatments/botox.html. Updated 2014. Accessed February 27, 2020.
;